Lewicki John A.

CIK 00015533522 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001553352

Recent Transactions

50 trades

Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+145,000→ 145,000 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+139,913→ 139,913 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+46,637→ 46,637 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2025-01-25+116,000→ 116,000 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-13$4.22/sh−10,937→ 78,630 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-12$4.47/sh−5,212→ 89,567 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Performance Based Restricted Stock Unit
2024-09-11−46,000→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-11+46,000→ 94,779 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-26$3.39/sh−16,808→ 48,779 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-25$3.69/sh−7,416→ 65,587 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-21+69,000→ 73,003 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Performance Based Restricted Stock Unit
2024-06-21+69,000→ 46,000 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2024-01-25+137,000→ 137,000 total
Disposition from Tender
OncoMed Pharmaceuticals Inc
Common Stock
2019-04-23−142,534→ 0 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2018-10-10$2.01/sh−1,156→ 55,966 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2018-10-09$2.13/sh−2,296→ 57,122 total
Gift
OncoMed Pharmaceuticals Inc
Common Stock
2018-08-06−11,793→ 44,173 total
Gift
OncoMed Pharmaceuticals Inc
Common Stock
2018-08-06+11,793→ 111,181 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2018-04-24$2.68/sh−4,557→ 55,418 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-03-16+125,000→ 125,000 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-02-21+125,000→ 125,000 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2017-10-10$4.24/sh−1,202→ 70,412 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2017-10-10$4.26/sh−46→ 71,614 total
Award
OncoMed Pharmaceuticals Inc
Common Stock
2017-10-07+25,000→ 71,660 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-10-07+50,000→ 50,000 total
Gift
OncoMed Pharmaceuticals Inc
Common Stock
2017-05-10−10,437→ 59,975 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-04-23+67,500→ 67,500 total
Award
OncoMed Pharmaceuticals Inc
Common Stock
2017-04-23+22,500→ 45,437 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2017-04-04$8.87/sh−43→ 28,648 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2017-04-04$9.06/sh−5,711→ 22,937 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-01-03+65,000→ 65,000 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2017-01-03$7.63/sh−9,175→ 31,636 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-01-03−9,175→ 0 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2017-01-03$1.43/sh+9,175→ 40,811 total
Award
OncoMed Pharmaceuticals Inc
Common Stock
2016-10-09+12,500→ 31,636 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2016-01-07$21.33/sh−1→ 17,838 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2016-01-06$21.56/sh−69→ 17,839 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2016-01-06$22.30/sh−2,092→ 17,908 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-12-27+70,000→ 70,000 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2015-06-16$3.42/sh+2,898→ 28,500 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2015-06-16$25.22/sh−8,500→ 20,000 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2015-06-16$1.43/sh+5,602→ 25,602 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-06-16−2,898→ 134,423 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-06-16−5,602→ 9,175 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-06-15−8,500→ 14,777 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2015-06-15$24.92/sh−8,500→ 20,000 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2015-06-15$1.43/sh+8,500→ 28,500 total
Sale
OncoMed Pharmaceuticals Inc
Common Stock
2015-04-02$25.29/sh−6,940→ 22,845 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-02+8,500→ 23,277 total
Exercise/Conversion
OncoMed Pharmaceuticals Inc
Common Stock
2015-04-02$1.43/sh+8,500→ 29,785 total

Companies

Recent Filings

Address

C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE

LONDON, X0, W1G 0QF

View on SEC.gov